# Exquisite Corporation – FDA Inspection, Apr 26, 2023

Source: https://www.keypedia.com/records/fda_inspections/exquisite-corporation/a92c52f0-0158-42ec-8881-84dd088a3415
Source feed: FDA_Inspections

> FDA inspection 1205627 of Exquisite Corporation, April 26, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205627
- Company Name: Exquisite Corporation
- Inspection Date: 2023-04-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1245264 - 2024-08-01](https://www.keypedia.com/records/fda_inspections/exquisite-corporation/95345e92-b26f-4201-a42b-a6dc10f58cab)
- FDA Inspection 815499 - 2013-01-09

## Related Officers

- [Company Rep](https://www.keypedia.com/people/heidy-c-perales/fdf71c74-8cb7-41b5-9070-6b8eb11cb404)

Company: https://www.keypedia.com/companies/exquisite-corporation/cf4dd029-0549-4ddb-b1f4-83e7a2559f7c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
